BOC to build plant for PowderJect:
This article was originally published in Clinica
UK gases company BOC is to build and operate the first commercial-scale plant to manufacture the helium microcylinder that powers PowderJect's needleless powder injection system. The plant, which will be capable of providing up to 50 million units per year, is expected to start production in early 2002. BOC has worked closely with Oxford-based PowderJect on the development and pilot manufacturing of the microcylinder since 1996. Under a new long-term agreement it will become the exclusive supplier for the injection device. PowderJect says that as its business grows BOC will also be responsible for adding further production capacity around the world.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.